spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 15 March 2005
doi: 10.1242/jcs.02280


Journal of Cell Science 118, 1515-1525 (2005)
Published by The Company of Biologists 2005
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piazza, T.
Right arrow Articles by Fabbi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piazza, T.
Right arrow Articles by Fabbi, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody

Tiziana Piazza1, Emanuela Cha2, Italia Bongarzone3, Silvana Canevari3, Andrea Bolognesi4, Letizia Polito4, Antonio Bargellesi5, Francesca Sassi1, Silvano Ferrini1,* and Marina Fabbi1

1 Istituto Nazionale per la Ricerca sul Cancro, Largo R. Benzi 10, 16132 Genova, Italy
2 Centro Biotecnologie Avanzate, Largo R. Benzi 10, 16132 Genova, Italy
3 Department of Experimental Oncology, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy
4 Department of Experimental Pathology, University of Bologna, Via S. Giacomo 14, 40126 Bologna, Italy
5 Department of Experimental Medicine, University of Genova, Via L. B. Alberti 2, 16132 Genova, Italy



View larger version (67K):

[in a new window]
 
Fig. 1. Characterization of the I/F8 antigen. (A) Immunoprecipitation from Sulfo-NHS-LC-biotin surface-labeled IGROV-I tumor cells using the I/F8 scFv coupled to CNBr-activated Sepharose beads. Immunoprecipitates were resolved by SDS-PAGE on a 10% polyacrylamide gel, and revealed by western blot analysis using HRP-conjugated Streptavidin and chemiluminescence. The I/F8 antigen is a 116 kDa monomer under both reducing (ME+) and non-reducing (ME–) conditions. Immunoprecipitates using an irrelevant scFv coupled to Sepharose beads were run as negative controls (ctr). (B) Silver-stained preparative immunoprecipitation and SDS-PAGE analysis of the I/F8 antigen. I/F8 immunoprecipitates from several tumor cell lines were resolved by SDS-PAGE on a 10% polyacrylamide gel under reducing conditions, and revealed by staining with silver nitrate. Bands were then excised from the gel and processed for MALDI-TOF analysis. (C) Immunofluorescence analysis of I/F8 (black line) and J4-81 (gray line) reactivity on various human and murine tumor cell lines. Broken line represents negative control with an irrelevant scFv. (D) Silver staining of I/F8 immunoprecipitated molecules from three murine tumor cell lines, resolved by SDS-PAGE on a 10% polyacrylamide gel. Numbers on left-hand side of blots indicate molecular weight markers in kDa.

 


View larger version (24K):

[in a new window]
 
Fig. 2. Cell surface binding interference experiments between ALCAM/CD166 ligands and the I/F8 scFv, measured by flow cytometry on N592 SCLC cells. Ligand binding in the presence of I/F8 is indicated by black triangles and binding in the presence of the irrelevant anti-NIP scFv is indicated by empty triangles. CD6/Fc and ALCAM/Fc chimeras were used at 10 and 100 nM respectively.

 


View larger version (91K):

[in a new window]
 
Fig. 3. I/F8-induced internalization of the ALCAM/CD166 molecule. IGROV-I cells were incubated with I/F8 scFv at 4°C in the presence (A,B,D) or in the absence (C) of the anti-FLAG-tag mAb as dimerizing agent. Cells were then placed on ice (A,B) or moved to 37°C for 30 minutes to induce internalization (C,D), and were subsequently untreated (A) or acid-washed to strip the surface-bound molecules (B-D). Samples were then fixed, permeabilized, stained with FITC-labeled secondary antibodies and visualized by using an Olympus confocal laser microscope system. Insets show staining with the irrelevant anti-NIP scFv as a negative control, except B where the Propidium Iodide-counterstained nuclei present in the same field are visualized. The residual staining detected in the stripped samples therefore corresponds to the endocytosed molecules. Magnification, 400 x.

 


View larger version (42K):

[in a new window]
 
Fig. 4. Internalization kinetics of ALCAM/CD166 compared to transferrin. (A) ALCAM/CD166 internalization is time dependent and slower than transferrin. Confocal microscopic imaging of IGROV-I cells incubated with I/F8 scFv and anti-FLAG mAb in the presence of transferrin-FITC. The samples were allowed to internalize for the indicated times (in minutes) before acid-stripping of the surface-bound molecules, fixing, permeabilizing and staining with RITC-labeled secondary antibody. Images were acquired sequentially as single transcellular optical sections, and the same section is shown stained with I/F8 (left panels) and with transferrin (right panels). Insets show the non-stripped samples. (B) Internalized ALCAM/CD166 distributes in the sub-membrane region and does not cluster toward the perinuclear area. Confocal microscopic imaging of IGROV-I cells stained with I/F8 plus anti-FLAG mAb, allowed to internalize for 60 minutes, acid-washed to strip the surface if required (right panel), fixed, permeabilized and stained with FITC-labeled secondary antibody. Nuclei were counterstained with Propidium Iodide. Magnification, 600 x.

 


View larger version (136K):

[in a new window]
 
Fig. 5. Internalized ALCAM/CD166 colocalizes primarily with clathrin. A2774 cells were stained either with I/F8 scFv plus anti-FLAG mAb (A,D) or with J4-81 mAb (B,E), allowed to internalize for 40 minutes at 37°C, acid-washed to remove the surface-bound antibody, fixed, permeabilized and stained with fluorochrome-labeled secondary antibody. As the colocalization with other molecules was investigated, the secondary antibody free valences were saturated by a 30-minute incubation with mouse IgG, followed by a second round of PFA fixation, and finally the cells were incubated with FITC-labeled anti-clathrin or with anti-caveolin antibodies. Anti-caveolin was then detected with RITC-labeled goat anti-mouse IgM antibody. As colocalizing positive controls, transferrin-RITC (TF, panel C) and cholera toxin B-FITC (CT B, panel F) were allowed to internalize for 10 and 40 minutes, respectively, at 37°C. Cells were then acid-washed, fixed, permeabilized and processed for staining with anti-clathrin and anti-caveolin antibodies. Double immunofluorescence was visualized by confocal microscopy. Single-color immunofluorescence images are shown in the small panels and the corresponding merged images are shown in the large panels. Original magnification, 600 x.

 


View larger version (104K):

[in a new window]
 
Fig. 6. Ligand-triggered internalization of the ALCAM/CD166 molecule is maximal at the dividing cell contact region. Confocal microscopic imaging of A2774 cells stained with I/F8 plus anti-FLAG mAb, kept on ice (A,D) or allowed to internalize for 40 minutes (B,C), acid-washed to strip the surface if required (B,C,D), fixed, permeabilized and stained with FITC-labeled secondary antibody. Nuclei were counterstained with Propidium Iodide (original magnification 600x).

 


View larger version (43K):

[in a new window]
 
Fig. 7. Ligand-induced internalization and recycling of ALCAM/CD166 molecules. (A) A2774 cells were surface-labeled with NHS-SS-biotin, incubated for 30 minutes at 37°C with or without the anti-ALCAM/CD166 mAb 3A6, treated with the reducing agent GSH, lysed and immunoprecipitated with I/F8 scFv coupled to Sepharose beads. Residual biotin-labeled molecules identify internalized proteins. (B) The kinetics of 3A6 mAb-triggered ALCAM/CD166 internalization was evaluated at different time points prior to GSH treatment and lysis. Optimal receptor internalization is at 40 minutes. The efficiency of surface NHS-SS-biotin stripping by GSH was evaluated at different time points on 3A6-treated cells maintained at 4°C. (C) To analyze receptor recycling, biotin-labeled and 3A6-treated A2774 cells were allowed to internalize ALCAM/CD166 for 40 minutes and were treated with GSH. Cells were then re-incubated at 37°C for 20 minutes to chase internalized receptors, and treated with (+) or without (–) the reducing agent to remove the label from molecules re-expressed to the cell surface. Cell lysis and I/F8-sepharose bead immunoprecipitation followed. Internalized ALCAM/CD166 recycles to the cell surface. (D) Kinetics of recycling. NHS-SS-biotin-labeled internalized receptors were chased by re-incubation at 37°C for different time points (t) before the second GSH treatment and immunoprecipitation. Immunoprecipitates were resolved by SDS-PAGE and revealed by western blot analysis with HRP-streptavidin and chemiluminescence.

 


View larger version (96K):

[in a new window]
 
Fig. 8. Internalization kinetics of the I/F8/RIP immunotoxin. A2774 cells were incubated with either I/F8/RIP (large and small left-hand panels) or RIP alone (small right-hand panels) at 4°C in the presence of the anti-RIP mAb CY12.14 as dimerizing agent. Cells were then left on ice (A,B) or transferred to 37°C for different times to induce internalization (C,D,E), and were subsequently untreated (small panels) or acid-washed to strip the surface-bound molecules (large panels). Samples were then fixed, permeabilized, stained by FITC-labeled secondary antibody and nuclei were counterstained with Propidium Iodide. Samples were visualized by using an Olympus confocal laser microscope system. Crosslinking the immunotoxin with anti-RIP mAb allowed the visualization of the internalized fraction at concentrations as low as 1 x10–8 M I/F8/RIP (about 0.2 µg/ml). This amount of immunotoxin was used, as it is the highest concentration that still shows a 100-fold difference in toxicity when compared to free RIP. Original magnification, 600 x.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2005